NCT05277753 2022-03-15
NGS-MRD Assessment of Combination Immunotherapies Targeting T-ALL
Shenzhen Geno-Immune Medical Institute
Phase 1 Unknown
Clinical Trials
3 trialsNCT05262673 2022-03-08
NGS-MRD Assessment of Combination Immunotherapies Targeting B-ALL
Shenzhen Geno-Immune Medical Institute
Phase 1 Unknown
NCT04085159 2020-06-12
Immunotherapy Based on Antigen-specific Immune Effector Cells Targeting Neurofibromatosis or Schwannomatosis
Shenzhen Geno-Immune Medical Institute
Phase 1/2 Unknown